Related Experiment Video

Updated: Feb 3, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses
12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

13.3K

Oncolytic cancer therapy with a vaccinia virus strain

Lili Deng1, Jun Fan1, Yuedi Ding1

  • 1Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu 214063, P.R China.

Oncology Reports
|October 27, 2018
PubMed

Insights

Chinese vaccinia strain VG9 shows promise as an oncolytic virotherapy agent. This study demonstrated its significant antitumor effects and ability to induce a cytotoxic T-lymphocyte response in a murine melanoma model.

Area of Science:

  • Oncolytic virotherapy
  • Cancer biology
  • Virology

Background:

  • Oncolytic vaccinia virus is being evaluated for cancer treatment, leveraging viral lysis for tumor eradication.
  • Various vaccinia strains are used, but the oncolytic efficacy of the Chinese Tian Tan strain (VTT) remains uncharacterized.
  • Vaccinia strain Guang9 (VG9), derived from VTT, exhibits greater attenuation than its parent strain.

Purpose of the Study:

  • To evaluate the oncolytic efficacy of the Chinese vaccinia strain VG9.
  • To assess VG9's in vitro replication, cytotoxicity, in vivo biodistribution, and antitumor effects.
  • To determine VG9's potential as a cancer therapeutic strategy.

Main Methods:

  • In vitro assessment of VG9 replication and cytotoxicity across different cell lines.
  • In vivo studies including biodistribution and antitumor efficacy evaluation in a B16 murine melanoma model.
  • Analysis of VG9-induced antitumor cytotoxic T-lymphocyte responses.

Main Results:

  • VG9 demonstrated rapid replication in vitro, with variable cytotoxicity depending on the cell line.
  • Significant antitumor effects were observed in the murine melanoma model.
  • VG9 successfully induced an antitumor cytotoxic T-lymphocyte response.

Conclusions:

  • The Chinese vaccinia strain VG9 shows potential as an oncolytic virotherapy agent.
  • VG9 holds promise for the development of recombinant vaccinia virus vectors for cancer treatment.
  • VG9 represents a potential therapeutic strategy for cancer therapy.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

9.5K
Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats08:55

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

9.9K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.4K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
What are Viruses?00:50

What are Viruses?

Overview
128.2K
Thermal Strain01:19

Thermal Strain

Thermal strain is a concept that arises when we consider how temperature changes affect structures. Unlike the conventional assumption that structures remain constant under load, real-world scenarios often involve temperature fluctuations that can significantly impact these structures. Consider a homogeneous rod with a uniform cross-section resting freely on a flat horizontal surface. If the rod's temperature increases, the rod elongates. This elongation is proportional to the temperature...
2.9K